Japan Fibrinogen Scandal Confirmed by PCR Testing

In Japan, the fibrinogen blood product scandal took a darker turn when later PCR testing found hepatitis C viral RNA in retained vials, confirming that some products had been contaminated. The finding mattered not just because it supported long-standing suspicions, but because it indicated old stock had remained in medical settings.

PCR Testing of Retained Vials

The key detail came from a Fuji TV investigation, which reportedly obtained retained vials of Green Cross fibrinogen and had them tested. PCR, a method used to detect viral genetic material, identified hepatitis C viral RNA in those samples. That shifted the story from historical risk to physical proof: contaminated fibrinogen was not only part of the past, it was reportedly still sitting in some clinics.

Fibrinogen products were used in Japan for patients needing help with blood clotting, including women treated for postpartum bleeding. For years, the broader scandal centered on whether blood-derived products had spread hepatitis C to patients before screening and safety systems improved. What made the later testing so significant was its precision. Instead of relying only on records, recollections, or probabilities, investigators pointed to actual vials and actual viral material.

Confirmed Contamination in Clinical Stock

That did not mean every vial everywhere was contaminated, and PCR detection in retained samples does not by itself reconstruct every chain of distribution. But it did confirm that contamination existed in real stock connected to clinical use. In a case already marked by delay and dispute, that kind of evidence carried unusual weight.

The consequence was larger than one broadcast or one manufacturer. It sharpened public understanding of how long dangerous medical products can remain in circulation after warnings, especially when systems for recall, disclosure, and disposal move slowly. It also reframed the harm: not only were patients exposed in earlier years, but the material evidence suggested the hazard had lingered physically on shelves.

Green Cross Fibrinogen Fallout

That is the concrete implication of the Green Cross fibrinogen story in Japan. The later PCR results did not merely imply that hepatitis C transmission might have happened decades earlier. They confirmed contaminated retained vials existed, and that some of those vials were reportedly still present in clinics long after the risk should have been removed.

Did You Know?